CTOs on the Move

Pocono ProFoods

www.poconoprofoods.com

 
At Pocono ProFoods, our innovative family distribution business is committed to fulfilling your foodservice needs for all segments of the foodservice business.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

All Seasonings Ingredients

All Seasonings Ingredients is a company that provides ingredients, spices, custom blends, and overall solutions for the food service and manufacturing industries.

Future Meat

Future Meat Technologies is a FoodTech company that`s racing towards bringing delicious and cost effective cultivated meat to the market by 2023! We opened the world`s first industrial line for cultured meat, with the power to scale production of delicious cultured products that every household will love.

Boise Co-op

Boise Co-op is a food cooperative founded in 1973 in Boise, Idaho, featuring natural foods from over 180 local and regional food producers.

Neptune Technologies and Bioressources

Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.